FDA Inspection 1179634 - GlaxoSmithKline Biologicals - September 13, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlaxoSmithKline Biologicals

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on September 13, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: GlaxoSmithKline Biologicals
Inspection Date: September 13, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · b7981ae6-29ac-4d33-bb97-b46c00e4538f

Violation Codes1

21 CFR 211.67(c)

Full citation text and observation details available on the Dashboard.